Insys Therapeutics Inc. filed for Chapter 11 protection in Delaware Monday listing more than $100 million in debt, just days after a $225 million global settlement ...
Insys Therapeutics shares fell around 45% on Monday morning after the specialty drug company announced it filed for chapter 11 bankruptcy as it grapples with ...
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Today's Pre-Open Movers. Provention Bio, Inc.
When Payless Shoesource exited Chapter 11 in August 2017, it had shed $435 million in debt and hundreds of stores. With a rightsized footprint and balance ...
Insys Therapeutics, Inc. (NASDAQ: INSY) shares are trading sharply lower following news the company initiated a court supervised process to facilitate asset ...